Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NowPatient vs WePeptideRx

NowPatient
Graded #217

Higher grade

vs+4.100000000000001
WePeptideRx
Graded #295

Lower grade

The verdict

NowPatient takes it — 65.5/100 to 61.4/100.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWePeptideRx +13
35
48
Dose & formulationNowPatient +29
93
64
Clinical oversightNowPatient +5
86
81
Labs & monitoringNowPatient +1
54
53
FulfillmentNowPatient +3
70
67
Contract termsEven
55
55
NowPatient · left barWePeptideRx · right bar

The numbers

MetricNowPatientWePeptideRx
WeighScore65.5/10061.4/100
GradeCC
Scorecard rank#217#295
Semaglutide$1,349/mo (brand Wegovy)$249/mo (compounded)
Tirzepatide$1,069/mo (brand Mounjaro, promotional rate)$249/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
NowPatient

Graded #217 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)
WePeptideRx

Graded #295 · C

Strengths

  • Pre-mixed ready-to-inject delivery skips the vial reconstitution and sharps hassle of most compounded providers
  • Microdose protocols (0.05–0.25 mg sema, 0.5–2.5 mg tirz) suit ultra-low-dose maintenance patients — uncommon in DTC
  • 12+ programs under one platform — GLP-1 plus longevity, sexual wellness, and hair
  • Physical Boca Raton address, phone, and business hours listed
  • LegitScript Certified and publishes the FDA disclaimer

Where it loses points

  • Pharmacy partner not named
  • 48-state claim, but the specific state list isn't shown on the homepage
  • Medical director not named on the homepage
  • Telemedicine is outsourced to a third-party provider network rather than in-house staff
  • Corporate legal entity and arbitration venue not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard